Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Emerging EDC and eClinical platform focused on decentralized trial capabilities with modern UX.
- Coverage: Global · Phase I–III
- Therapeutic focus: Oncology, Rare diseases, Neurology, Immunology
- Scale: Small,Medium
Company fit
Best suited for
Modern EDC for DCT,Small-to-mid biotech,Cost-effective eClinical
Study fit
Good fit for biotechs wanting modern EDC with DCT capabilities at competitive pricing.
Core strengths
- Modern UX design
- DCT-native features
- Competitive pricing
Considerations
- Smaller market presence
- Limited enterprise track record
Key facts
- Category
- EDC / eClinical
- Geography
- Global
- Service model
- SaaS
- Vendor type
- Technology
- HQ
- United States